Loading Events

« All Events

  • This event has passed.

Ferric Carboxymaltose for Heart Failure – ISCP Online Webinar Series

April 13 @ 6:00 pm - 7:00 pm

Ferric Carboxymaltose: Ironing Out the Issues Around Heart Failure Related Readmissions

Part of the A-Z of CV Pharmacotherapy Webinar Series from the ISCP.

13th April 2022 | 11:00 BST | 18:00 SGT

Do you know when, how and on which patients to use ferric carboxymaltose to treat heart failure?

Iron deficiency can have a negative impact on both mitochondrial and cardiac function and on the structure of the heart, this can lead to heart failure. Ferric carboxymaltose can improve both cardiac structure and performance.

This webinar is the first in a series of six webinars from the ISCP focusing on the A to Z of CV Pharmacotherapy. Led by moderators Chan Hong (Singapore) and Franco Cheng (Hong Kong), it includes a speaker presentation from David Sim (Singapore) and a discussion from panellists Maurizio Volterrani (Italy) and Daniel Lighezan (Romania) that will examine the importance of ferric carboxymaltose, through consideration of real-world examples, live discussions and audience Q&A.

Performed By:

David Sim
 Maurizio Volterrani
 Daniel Lighezan

David Sim, Maurizio Volterrani, Daniel Lighezan

Moderated By:

Chan Hong
 Franco Cheng

Chan Hong, Franco Chen

Key learning objectives

  • To evaluate and understand the importance of iron in Heart Failure
  • To evaluate and understand when and how to use ferric carboxymaltose in Heart Failure
  • To apply evidence-based recommendations to two real world cases

Target audience

  • Cardiovascular team members – Doctors, nurses and Pharmacists
  • Family Physicians
  • Internists
  • Healthcare students
  • Cardiovascular pharmacotherapy researchers

Venue

Online Webinar

Organiser

International Society of Cardiovascular Pharmacology (ISCP)
View Organiser Website